http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Bradford A. Young, Ph.D., MBA Joins Pressure BioSciences as Chief Commercial Officer
-
Pressure BioSciences Accelerates Development of Novel Ultra Shear Technology Platform to Pursue Commercialization into Major New Markets
-
Pressure BioSciences' Ultra High Pressure Instruments, Processing Methods, and Platform Technologies Prominently Featured at Leading Food Science Meeting
-
Pressure BioSciences Announces Commercial Release of the HUB880 Explorer
-
Pressure Biosciences, Inc. (PBIO) Granted U.S. Patent for Novel High-Pressure Flow-Through Microfluidic Sample Preparation Device
-
Pressure BioSciences Awarded Key U.S. Patent for Novel High-Pressure Flow-Through Microfluidic Sample Preparation Device
-
Pressure BioSciences, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update
-
Pressure BioSciences, Inc. to Discuss Second Quarter 2018 Financial Results and Provide Business Update
-
Pressure BioSciences Developing Potential Breakthrough Processing Method for High Quality, Shelf Stable Milk and Other Dairy Products
-
Pressure BioSciences Converts Additional $7.24M of Debt into Equity: Total Conversions Exceed $13.6M in Past 30 Days
-
Pressure BioSciences, Inc. Reports First Quarter 2018 Financial Results and Provides Business Update
-
Pressure BioSciences, Inc. to Discuss First Quarter 2018 Financial Results and Provide Business Update
-
Pressure BioSciences, Inc., a Leader in the Development & Sale of Pressure-Based Solutions for the Worldwide Life Sciences Market, to Host Webinar Update for Investors
-
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Discusses Strong Finish to 2017 and Operational Developments for 2018 on Uptick Newswire’s “Stock Day” Podcast with Everett Jolly
-
Pressure BioSciences, Inc. Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Provides Business Update
-
Pressure BioSciences, Inc. to Discuss Fourth Quarter and FY2017 Financial Results and Provide Business Update
-
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Review Significant Achievements in 2017 and Discuss Exci
-
Pressure BioSciences, Inc. and ISS, Inc. Announce Two-Year Worldwide Co-Marketing and Distribution Agreement
-
Pressure BioSciences, Inc., a Leader in the Sale of Pressure-Based Solutions for the Worldwide Life Sciences Market, to Host Webinar Update for Investors
-
Pressure BioSciences Enters Biopharmaceutical Quality Control Market with Significant Software Upgrade for Its Flagship Barocycler 2320EXTREME
-
Pressure BioSciences, Inc. to Host Business Update on Wednesday, December 20th at 4:30 pm EST
-
Pressure BioSciences Announces Acquisition of All Assets of BaroFold, Inc.
-
Pressure BioSciences, Inc. Reports Third Quarter 2017 Financial Results and Provides Business Update
-
UPDATE – Uppie Award Winners and Show Recap
-
Pressure BioSciences, Inc. to Discuss Third Quarter 2017 Financial Results and Provide Business Update
-
Pressure BioSciences Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion into China
-
Pressure BioSciences and Phasex Announce Strategic Collaboration Addressing Broad Markets for Stable, Water-Soluble Nanoemulsions
-
Pressure BioSciences' Penetration in European Biopharma and High Pressure Markets Continuing to Expand via Multiple Scientific Presentations in Germany, Poland, and Ireland
-
CEO Richard T. Schumacher Discusses Pressure BioScience’s New Sales Team and Novel Products that are Fueling its Progressive Upturn
-
Pressure BioSciences, Inc. Issued First Two Patents on Widely-Applicable, High Pressure-Based Ultra Shear Technology ("UST")
-
Pressure BioSciences' Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards
-
Pressure BioSciences, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on September 11, 2017
-
Pressure BioSciences, Inc. Reports Second Quarter 2017 Financial Results and Provides Business Update
-
Pressure BioSciences, Inc. to Discuss Second Quarter 2017 Financial Results and Provide Business Update
-
Dr. Ruedi Aebersold Receives the Prestigious Karger Medal Recognizing an Individual Who Has Significantly Contributed to the Development of New Bioanalytical Methods
-
Pressure BioSciences, Inc. Announces One-for-Thirty Reverse Stock Split
-
Pressure BioSciences, Inc. Reports First Quarter 2017 Financial Results and Provides Business Update
-
Pressure BioSciences, Inc. to Discuss First Quarter 2017 Financial Results and Provide Business Update
-
Pressure BioSciences, Inc. Appoints Joseph L. Damasio Jr. as Vice President of Finance and Chief Financial Officer
-
Pressure BioSciences, Inc. Significantly Expands Marketing and Sales Capabilities
-
Pressure BioSciences, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Provides Business Update
-
Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2016 Financial Results and Provide Business Update
-
Pressure BioSciences Receives 2017 North American Excellence Award: "Best New Instrument for Sample Preparation"
-
Pressure BioSciences, Inc. Discusses Research Market, Goals and Milestones for First Half of 2017 in New SNNLive Video Interview with StockNewsNow.com
-
Pressure BioSciences Achieves CE Marking for its Next Generation Sample Preparation Instrument, the Barocycler 2320EXTREME
-
Pressure BioSciences, Inc. to Present at RedChip's Global Online Growth Conference
-
Pressure BioSciences, Inc. to Present at the 2017 Biotech Showcase
-
Pressure BioSciences, Inc. Well Positioned to Play Important Role in US's $1.8 Billion "Cancer Moonshot" Initiative
-
Pressure BioSciences, Inc. Reports Third Quarter 2016 Financial Results and Provides Business Update
-
Pressure BioSciences Announces Initial Close of $610,000 in $2.5 Million Private Placement

